Tags

Type your tag names separated by a space and hit enter

Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
S Afr Med J. 1983 Jul 09; 64(2):54-6.SA

Abstract

A trial of etretinate (Tigason) for keratinizing disorders of the skin yielded prolonged improvements beyond any results hitherto obtained. The disorders included psoriasis of severe degree, keratosis obturans, ichthyosis vulgaris, follicular ichthyosis, porokeratosis of Nékam, disseminated superficial actinic porokeratosis. Darier's disease, palmoplantar keratoderma, Oudtshoorn disease, lamellar ichthyosis, 'badpak' ichthyosis, epidermolytic hyperkeratosis, the 'half-baby' syndrome, exfoliative dermatitis, hair dystrophy and selected precancerous conditions. A method of management which worked well under local conditions is outlined.

Authors

No affiliation info available

Pub Type(s)

Case Reports
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

6867876

Citation

Findlay, G H.. "Intractable Skin Disorders Treated With the Aromatic Retinoid Etretinate (Tigason). Two and a Half Years' Experience in the Transvaal." South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, vol. 64, no. 2, 1983, pp. 54-6.
Findlay GH. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. S Afr Med J. 1983;64(2):54-6.
Findlay, G. H. (1983). Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 64(2), 54-6.
Findlay GH. Intractable Skin Disorders Treated With the Aromatic Retinoid Etretinate (Tigason). Two and a Half Years' Experience in the Transvaal. S Afr Med J. 1983 Jul 9;64(2):54-6. PubMed PMID: 6867876.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal. A1 - Findlay,G H, PY - 1983/7/9/pubmed PY - 1983/7/9/medline PY - 1983/7/9/entrez SP - 54 EP - 6 JF - South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde JO - S Afr Med J VL - 64 IS - 2 N2 - A trial of etretinate (Tigason) for keratinizing disorders of the skin yielded prolonged improvements beyond any results hitherto obtained. The disorders included psoriasis of severe degree, keratosis obturans, ichthyosis vulgaris, follicular ichthyosis, porokeratosis of Nékam, disseminated superficial actinic porokeratosis. Darier's disease, palmoplantar keratoderma, Oudtshoorn disease, lamellar ichthyosis, 'badpak' ichthyosis, epidermolytic hyperkeratosis, the 'half-baby' syndrome, exfoliative dermatitis, hair dystrophy and selected precancerous conditions. A method of management which worked well under local conditions is outlined. SN - 0256-9574 UR - https://www.unboundmedicine.com/medline/citation/6867876/Intractable_skin_disorders_treated_with_the_aromatic_retinoid_etretinate__Tigason___Two_and_a_half_years'_experience_in_the_Transvaal_ L2 - https://medlineplus.gov/skinconditions.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.